MICHAEL 

 

DIAL 

EXECUTIVE OFFICER

CLINICAL FUTURE, INC.   |  CUROVERSE, INC.   |  KINODYN, INC.   |  RIBOMETRIX, INC.   |  HATTERAS VENTURE PARTNERS VI, LP   |  ATSENA THERAPEUTICS, INC.   |  HATTERAS VENTURE PARTNERS VII, LP   |  HATTERAS OPPORTUNITY FUND I, LP   |  ALTIS BIOSYSTEMS, INC.   |  HATTERAS CREATE SF SPV, LLC

LEE 

M. 

GRAVES 

EXECUTIVE OFFICER

KINODYN, INC.

GARY 

L. 

JOHNSON 

DIRECTOR, EXECUTIVE OFFICER

KINODYN, INC.

NATHAN 

P. 

LETTS 

EXECUTIVE OFFICER

KINODYN, INC.

CHRISTY 

 

SHAFFER 

DIRECTOR

CLINIPACE INC   |  EVOAPP, INC.   |  CLEARSIDE BIOMEDICAL, INC.   |  G-ZERO THERAPEUTICS, INC.   |  G1 THERAPEUTICS, INC.   |  KINODYN, INC.   |  SPYRYX BIOSCIENCES, INC.   |  HATTERAS VENTURE PARTNERS V, LP   |  GRAYBUG, INC.   |  TREFOIL THERAPEUTICS, INC.   |  GRAYBUG VISION, INC.   |  ARTIZAN BIOSCIENCES, INC.   |  PERFUSE THERAPEUTICS, INC.   |  HATTERAS VENTURE PARTNERS VI, LP   |  AER THERAPEUTICS, INC.   |  HATTERAS VENTURE PARTNERS VII, LP   |  HATTERAS OPPORTUNITY FUND I, LP   |  HATTERAS CREATE SF SPV, LLC

HOLDEN 

 

THORPE 

DIRECTOR

KINODYN, INC.